Someone told you to see a neuro-optometrist. Maybe your primary care doctor after a concussion that didn't fully resolve. Maybe a forum post, a friend, or this blog.
You looked it up. The nearest clinician is 90 minutes away, not in your insurance network, with a first appointment of $200 to $400 out of pocket and a website talking about therapies you haven't heard of. The reasonable question: is this worth it, and what actually happens in the room?
This post is the practical walk-through — what a neuro-optometrist is, when the referral is worth pursuing, what the first appointment measures, what "vision therapy" looks like, what the evidence says, what to bring and what to ask.
What a neuro-optometrist is
A neuro-optometrist is an optometrist with additional training in vision as a brain function, not only as an eye function. The standard exam centres on refraction and ocular health. Neuro-optometric rehabilitation centres on how the visual system uses what the eyes provide — how the two eyes coordinate, how the gaze moves, how vision pairs with balance and movement.
Most neuro-optometrists carry credentials through the Neuro-Optometric Rehabilitation Association (NORA) or the Optometric Vision Development & Rehabilitation Association (OVDRA), the rebranded former COVD. NORA leans toward post-injury and post-stroke rehabilitation, OVDRA toward developmental and learning-related care, and many providers hold both.
The simplest distinction: a general optometrist answers do your eyes need correction and are they healthy. An ophthalmologist handles medical and surgical disease of the eye. A neuro-optometrist handles the functional layer — the things that go wrong when the eyes themselves look fine but the visual system is not doing the work you need it to do.
When the referral is worth pursuing
Common reasons a referral is appropriate:
- Persistent visual symptoms after concussion — reading fatigue, near-vision blur, words drifting, light sensitivity, the week-by-week recovery plateauing past the textbook window.
- Post-stroke reading or visual-field changes when the standard eye exam reads as unremarkable.
- Persistent visual symptoms in Long COVID — see our Long COVID post.
- Adult-onset reading difficulty without a clear refractive cause — losing place, near-work feeling effortful in ways an updated prescription hasn't fixed.
- Migraine with visual aura affecting daily function between attacks.
- Vestibular-visual symptoms — motion sensitivity, supermarket-aisle disorientation, the floor feeling unstable in busy visual environments.
The common thread: the eye exam says you are fine, and your day-to-day vision says you are not.
What the first appointment looks like
A first evaluation runs 60 to 90 minutes, sometimes longer. Most of that time is testing — substantially more than a standard exam. The order varies; the modules are fairly consistent.
Intake (about 30 minutes). Detailed symptom inventory, medical and injury history, prior eye care, what your typical reading and screen day looks like. If you have been tracking your contrast sensitivity, this is where it enters the conversation. Expect questions about sleep, headaches, dizziness, screen time — diagnostic, not small talk.
Refraction and ocular health. The lens-by-lens "better one or two" plus front- and back-of-the-eye exam, sometimes dilated. Rules out structural problems before functional ones are pursued.
Binocular vision testing. How the two eyes coordinate. Includes convergence (eyes pulling together for near work), divergence (relaxing for distance), and fusional reserves (how much demand the system absorbs before breaking down). Often the most concussion-relevant module.
Accommodation testing. How quickly and accurately the eyes focus near to far and back. Commonly affected by concussion and other neurological events. You alternate gaze between near and far targets while the clinician measures speed and stability.
Sensorimotor testing. Eye-movement quality. Pursuits — smooth tracking of a moving target. Saccades — quick, accurate jumps between targets, the movement underlying reading. Fixation stability — holding steady on a single point.
Visual fields. Confrontation or formal automated perimetry, depending on history.
Special modules, if relevant. Vestibular-ocular reflex testing, balance assessment with and without visual input, light-sensitivity testing, reading-rate measurement, sometimes quantitative eye-tracking instrumentation.
At the end, the clinician walks you through findings in plain English, with the specific functional problems named. A written report follows. If therapy is recommended, you should leave knowing why, what it involves, and how progress will be measured.
What "vision therapy" actually involves
If the evaluation finds a treatable functional problem, the clinician may recommend a course of vision therapy — sometimes called neuro-optometric rehabilitation or orthoptic therapy.
In-office sessions. 45 to 60 minutes, once a week, for 12 to 24 weeks. Run by the optometrist or by a trained vision therapist under their supervision.
Home exercises. 10 to 20 minutes daily between sessions. Without the home component, in-office work tends to fade.
Common exercises. A Brock string (a long string with three coloured beads, training convergence at varying distances). Vergence flippers (a flip-lens device that trains the eyes to relax and tighten convergence quickly). Pencil push-ups. Saccadic tracking charts. Hart charts for accommodation. Computer-based exercises for smooth pursuit, peripheral awareness, processing speed. Sometimes balance-board work paired with visual tasks.
Lenses and prisms. Sometimes the answer is partly optical — a low-power reading prescription, prism in your glasses to ease near work, tints for light sensitivity.
Vestibular integration. If motion sensitivity is part of the picture, exercises pairing head movement with visual stabilisation enter the rotation.
A good clinic explains, at the start, what they expect to change, in what timeframe, and how they will measure it. Objective markers — convergence near-point in centimetres, accommodative facility in cycles-per-minute, fusional reserve in prism dioptres — give both you and the clinician a way to see whether the work is doing what it should.
What the evidence says — honestly
The evidence base is not uniform across the conditions a neuro-optometrist treats.
Strongest evidence — convergence insufficiency in children. The Convergence Insufficiency Treatment Trial randomised 221 children aged 9 to 17 to four arms (home pencil push-ups, home computer therapy, office-based vergence/accommodative therapy, placebo office condition). After 12 weeks, about 75% of the office-therapy group met success criteria, versus 43% (home computer), 33% (home push-ups), and 35% (placebo) (Convergence Insufficiency Treatment Trial Study Group, 2008). The load-bearing modern citation for vision therapy as an evidence-based treatment.
Emerging positive evidence — vision therapy for post-concussion CI. The CONCUSS trial (Alvarez et al., 2025), in the British Journal of Sports Medicine, applied office-based vergence/accommodative therapy to patients aged 11 to 25 with concussion-related convergence insufficiency persisting past one month. The therapy group improved markedly more than the comparison condition on both clinical measures and symptom scores. The first high-quality RCT extending the CITT result into the post-concussion setting — sharpening the case for therapy when CI is the specific finding, not for post-concussion broadly.
Less validated — post-trauma vision syndrome, yoked prism, visual midline shift. The 2022 Consensus Statement on Visual Rehabilitation in Mild TBI, jointly produced by the American Academy of Ophthalmology and the North American Neuro-Ophthalmology Society, concluded that diagnoses such as post-trauma vision syndrome, visual midline shift, and vertical heterophoria — and treatments built on them — rest on case reports and case series rather than controlled trials (Subramanian et al., 2022). The original framework (Padula & Argyris, 1996) remains influential; the controlled-trial evidence is not where the convergence-insufficiency evidence is.
The honest framing: vision therapy works well for what it works well for, and the strongest case is convergence insufficiency, including in concussion. For other targets, the practice is more variable. The right question to ask is what specific finding is being treated and what evidence supports that treatment.
Cost and insurance, plainly
Most neuro-optometrists are out-of-network for vision insurance (the kind that covers refraction). Medical-insurance coverage is uneven. Typical US ranges:
- Initial evaluation: $200 to $500.
- Individual therapy sessions: $50 to $150.
- A 12-to-24-week course: $1,500 to $4,000.
A few practical notes. Some medical insurance covers post-TBI vision rehabilitation when coded as occupational therapy or as medically-necessary diagnostic service — worth a phone call to your insurer with the CPT codes the clinic plans to use. HSA and FSA accounts typically cover these expenses. Asking for a superbill (so you can submit for out-of-network reimbursement yourself) is reasonable and routine.
If cost is the limiting factor and the question is whether to go at all, one reasonable middle path: book the evaluation alone, then decide about a therapy course separately. The evaluation by itself often clarifies whether a course is the right next step.
What to bring
The appointment goes better with the inputs gathered.
- A dated symptom timeline — when each started, what makes it better or worse, what specific tasks have changed. One page is plenty.
- Prior eye exam records.
- A current medication list, including over-the-counter and supplements.
- If you have been tracking your contrast sensitivity at home, the share-link URLs for your three or four most recent readings.
- Specific task examples — driving at dusk, reading email after lunch, recognising faces in restaurants. Concrete beats abstract.
What to ask
Four questions that earn their keep, regardless of the finding.
- Is this a condition where vision therapy is well-validated, or one where the evidence is still emerging? The honest answer separates convergence-insufficiency cases from the more exploratory ones.
- What is the expected timeline, and what objective markers will we use to track it? Vague answers here are a warning sign.
- If we do not see improvement in 8 to 12 weeks, what is the plan? A clinician who has not thought about the negative case is worth more questions.
- Should I also see a neurologist, vestibular therapist, or other specialist? Vision rarely fails in isolation.
What it cannot fix
Worth stating plainly. Neuro-optometric rehabilitation does not repair structural damage to the eye, optic nerve, or visual cortex. It does not reverse macular degeneration, glaucomatous nerve loss, or post-stroke cortical infarction. It does not treat the underlying neurological condition. What it can do is help the visual system make better use of the equipment it has — training compensatory strategies, optimising binocular coordination, reducing the load on over-working parts of the system. A real and useful thing, and a different thing from a cure.
Note. Vision therapy is one treatment among several you may be offered. The evidence for it is strong for some indications (convergence insufficiency, including post-concussion CI) and weaker for others (broader post-trauma vision syndrome frameworks). A neuro-optometric evaluation does not replace neurological, vestibular, or ophthalmological care when those are indicated, and the best outcomes in complex cases usually involve coordinated work across more than one specialty.
Take the test, save the trend, bring it
If an appointment is on the calendar — or you are still deciding — a few weeks of contrast sensitivity tracking on the same device, in similar lighting, is one of the more useful inputs you can show up with. It does not replace any of the testing above. It does give the conversation a longitudinal record the appointment otherwise would not have.
Take the test now, save the share link, retake in a week or two. Bring the links to your appointment. The evaluation will do its own measurement; your record sits alongside it.
References
- Convergence Insufficiency Treatment Trial Study Group. (2008). Randomized clinical trial of treatments for symptomatic convergence insufficiency in children. Archives of Ophthalmology, 126(10), 1336–1349. The 221-child, four-arm, placebo-controlled trial that established office-based vergence/accommodative therapy as the most effective treatment for symptomatic convergence insufficiency. Roughly 75% of office-therapy patients met success criteria at 12 weeks, versus 43% (home computer therapy plus pencil push-ups), 33% (home pencil push-ups), and 35% (office placebo). The load-bearing modern citation for vision therapy as evidence-based intervention.
- Alvarez, T. L., Scheiman, M., Santos, E. M., Yaramothu, C., d'Antonio-Bertagnolli, J. V., Biswal, B. B., Gohel, S., & Li, X. (2025). CONCUSS randomised clinical trial of vergence/accommodative therapy for concussion-related symptomatic convergence insufficiency. British Journal of Sports Medicine. DOI: 10.1136/bjsports-2025-109807. RCT in patients aged 11–25 with concussion-related CI persisting past one month post-injury; office-based vergence/accommodative therapy produced significantly greater improvements in clinical measures and symptom severity than the comparison condition. The first high-quality RCT extending the CITT framework into the post-concussion setting.
- Subramanian, P. S., Barton, J. J. S., Ranalli, P., Smith, C., Francis, C. E., & Frishberg, B. (2022). Consensus Statement on Visual Rehabilitation in Mild Traumatic Brain Injury. Neurology: Clinical Practice, 12(6), 422–428. Joint consensus from the American Academy of Ophthalmology and the North American Neuro-Ophthalmology Society. Concludes that diagnoses such as post-trauma vision syndrome, visual midline shift syndrome, and vertical heterophoria — and their associated treatments — rest on case reports and case series rather than controlled trials. The honest counterweight to the CITT/CONCUSS evidence where the neuro-optometric evidence base is thinner.
- Padula, W. V., & Argyris, S. (1996). Post trauma vision syndrome and visual midline shift syndrome. NeuroRehabilitation, 6(3), 165–171. The original articulation of post-trauma vision syndrome as a clinical entity, including the focal/ambient framework and yoked-prism treatment. Influential within neuro-optometric practice; cited here alongside Subramanian et al. (2022) so the patient sees both halves of the picture before pursuing a treatment built on the framework.